# PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

> **NCT07023094** · PHASE4 · RECRUITING · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Hip Disease
- Hip Dysplasia
- Hip Arthropathy

## Interventions

- **DRUG:** Ropivacaine 0.2% for PENG Block
- **DRUG:** Ropivacaine 0.2% for LFCB
- **DRUG:** Ropivacaine 0.2% for L-ESPB
- **DRUG:** Ropivacaine 0.2% for S-ESPB

## Key facts

- **NCT ID:** NCT07023094
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-16
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07023094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07023094, "PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07023094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*